A 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer's disease.

Imbimbo, B P

A 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer's disease. [electronic resource] - Dementia and geriatric cognitive disorders - 17-24 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1420-8008

10.1159/000017208 doi


Aged
Aged, 80 and over
Alzheimer Disease--diagnosis
Cholinesterase Inhibitors--administration & dosage
Dose-Response Relationship, Drug
Double-Blind Method
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neuropsychological Tests
Physostigmine--administration & dosage
Treatment Outcome